Revolution Medicines, Inc. SEC filings RVMDW
Revolution Medicines, Inc. has 862 filings in SEC EDGAR's recent list, going back to Dec 21, 2016. Its latest annual report, Form ARS, was filed on Apr 28, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 4, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 4, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Results of operations
|
Nov 4, 2026 | Nov 4, 2026 |
| 8-K |
Current report
New debt, Other events
|
Oct 13, 2026 | Oct 8, 2026 |
| 8-K |
Current report
Material agreement, New debt
|
Sep 1, 2026 | Aug 27, 2026 |
| 8-K |
Current report
Other events
|
Aug 26, 2026 | Aug 26, 2026 |
| 8-K |
Current report
Results of operations
|
Aug 5, 2026 | Aug 5, 2026 |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
Jun 22, 2026 | Jun 18, 2026 |
| 8-K |
Current report
Results of operations
|
May 6, 2026 | May 6, 2026 |
| 8-K |
Current report
Material agreement, New debt, Other events
|
Apr 17, 2026 | Apr 14, 2026 |
| 8-K |
Current report
Other events
|
Apr 16, 2026 | Apr 14, 2026 |
| 8-K |
Current report
Other events
|
Apr 13, 2026 | Apr 13, 2026 |
| 8-K |
Current report
Results of operations
|
Feb 25, 2026 | Feb 25, 2026 |
| 8-K |
Current report
Results of operations
|
Nov 5, 2025 | Nov 5, 2025 |
| 8-K |
Current report
Other events
|
Oct 17, 2025 | Oct 16, 2025 |
| 8-K |
Current report
Other events
|
Sep 10, 2025 | Sep 10, 2025 |
| 8-K |
Current report
Results of operations
|
Aug 6, 2025 | Aug 6, 2025 |
| 8-K |
Current report
Shareholder vote results
|
Jun 27, 2025 | Jun 26, 2025 |
| 8-K |
Current report
Material agreement, New debt, Regulation FD disclosure
|
Jun 24, 2025 | Jun 23, 2025 |
| 8-K |
Current report
Officer or director change
|
Jun 18, 2025 | Jun 18, 2025 |
| 8-K |
Current report
Results of operations
|
May 7, 2025 | May 7, 2025 |
| 8-K |
Current report
Results of operations
|
Feb 26, 2025 | Feb 26, 2025 |
| 8-K |
Current report
Other events
|
Dec 5, 2024 | Dec 3, 2024 |
| 8-K |
Current report
Other events
|
Dec 2, 2024 | Dec 2, 2024 |
| 8-K |
Current report
Results of operations
|
Nov 6, 2024 | Nov 6, 2024 |
| 8-K |
Current report
Other events
|
Oct 25, 2024 | Oct 25, 2024 |
| 8-K |
Current report
Other events
|
Oct 23, 2024 | Oct 23, 2024 |
| 8-K |
Current report
Results of operations, Officer or director change
|
Aug 7, 2024 | Aug 5, 2024 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Jul 15, 2024 | Jul 15, 2024 |
| 8-K |
Current report
Shareholder vote results
|
Jun 24, 2024 | Jun 20, 2024 |
| 8-K |
Current report
Results of operations
|
May 8, 2024 | May 8, 2024 |
| 8-K |
Current report
Results of operations
|
Feb 26, 2024 | Feb 26, 2024 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Jan 9, 2024 | Jan 9, 2024 |
| 8-K/A | Amended current report | Dec 26, 2023 | Nov 8, 2023 |
| 8-K |
Current report
Acquisition or sale of assets, Officer or director change, Shareholder vote results, Regulation FD disclosure
|
Nov 9, 2023 | Nov 8, 2023 |
| 8-K |
Current report
Results of operations
|
Nov 6, 2023 | Nov 6, 2023 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Nov 1, 2023 | Nov 1, 2023 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Oct 23, 2023 | Oct 22, 2023 |
| 8-K |
Current report
Other events
|
Oct 13, 2023 | Oct 13, 2023 |
| 8-K |
Current report
Officer or director change
|
Sep 5, 2023 | Aug 31, 2023 |
| 8-K |
Current report
Results of operations
|
Aug 8, 2023 | Aug 8, 2023 |
| 8-K |
Current report
Material agreement, Regulation FD disclosure, Other events
|
Aug 1, 2023 | Jul 31, 2023 |
| 8-K |
Current report
Shareholder vote results
|
Jun 9, 2023 | Jun 8, 2023 |
| 8-K |
Current report
Results of operations
|
May 8, 2023 | May 8, 2023 |
| 8-K |
Current report
Other events
|
Mar 7, 2023 | Mar 2, 2023 |
| 8-K |
Current report
Results of operations
|
Feb 27, 2023 | Feb 27, 2023 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Jan 10, 2023 | Jan 10, 2023 |
| 8-K |
Current report
Agreement ended
|
Dec 7, 2022 | Dec 6, 2022 |
| 8-K |
Current report
Results of operations
|
Nov 7, 2022 | Nov 7, 2022 |
| 8-K |
Current report
Officer or director change
|
Sep 1, 2022 | Sep 1, 2022 |
| 8-K |
Current report
Results of operations
|
Aug 9, 2022 | Aug 9, 2022 |
| 8-K |
Current report
Other events
|
Jul 22, 2022 | Jul 19, 2022 |
| 8-K |
Current report
Officer or director change
|
Jul 13, 2022 | Jul 9, 2022 |
| 8-K |
Current report
Shareholder vote results
|
Jun 21, 2022 | Jun 16, 2022 |
| 8-K |
Current report
Officer or director change
|
Jun 10, 2022 | Jun 8, 2022 |
| 8-K |
Current report
Results of operations
|
May 9, 2022 | May 9, 2022 |
| 8-K |
Current report
Results of operations
|
Feb 28, 2022 | Feb 28, 2022 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure, Other events
|
Jan 11, 2022 | Jan 11, 2022 |
| 8-K |
Current report
Results of operations
|
Nov 10, 2021 | Nov 10, 2021 |
| 8-K |
Current report
Material agreement, New debt
|
Nov 4, 2021 | Nov 1, 2021 |
| 8-K |
Current report
Results of operations
|
Aug 11, 2021 | Aug 11, 2021 |
| 8-K |
Current report
Shareholder vote results
|
Jun 23, 2021 | Jun 22, 2021 |
| 8-K |
Current report
Results of operations
|
May 10, 2021 | May 10, 2021 |
| 8-K |
Current report
Regulation FD disclosure
|
Apr 30, 2021 | Apr 30, 2021 |
| 8-K |
Current report
Officer or director change, Bylaw or fiscal year change
|
Mar 8, 2021 | Mar 4, 2021 |
| 8-K |
Current report
Results of operations
|
Mar 2, 2021 | Mar 2, 2021 |
| 8-K |
Current report
Results of operations
|
Feb 1, 2021 | Feb 1, 2021 |
| 8-K |
Current report
Results of operations
|
Nov 12, 2020 | Nov 12, 2020 |
| 8-K |
Current report
Results of operations
|
Aug 10, 2020 | Aug 10, 2020 |
| 8-K |
Current report
Regulation FD disclosure
|
Jun 22, 2020 | Jun 22, 2020 |
| 8-K |
Current report
Officer or director change
|
Jun 18, 2020 | Jun 17, 2020 |
| 8-K |
Current report
Results of operations
|
May 14, 2020 | May 14, 2020 |
| 8-K |
Current report
Material agreement, New debt, Other events
|
Apr 21, 2020 | Apr 17, 2020 |
| 8-K |
Current report
Officer or director change
|
Mar 20, 2020 | Mar 18, 2020 |
| 8-K |
Current report
Bylaw or fiscal year change, Other events
|
Feb 18, 2020 | Feb 18, 2020 |
Showing 73 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Biological Products, (No Diagnostic Substances) (SIC 2836)
- Listed as
- RVMD (Nasdaq), RVMDW (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Redwood City, CA
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1628171
Other Biological Products, (No Diagnostic Substances) companies
- Amgen Inc AMGN
- Gilead Sciences, Inc. GILD
- Moderna, Inc. MRNA
- Argenx SE ARGX
- Biogen Inc. BIIB
- BioNTech SE BNTX
- Exelixis, Inc. EXEL
- Neurocrine Biosciences Inc NBIX
All 182 Biological Products, (No Diagnostic Substances) companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.